China BlueChemical Ltd Class H (HK:3983)
:3983
Top Page
China BlueChemical
(3983)
Select Model
Select Model
Rating:70Outperform
Price Target:
HK$3.00
▲(20.00% Upside)
Action:UpgradedDate:11/14/25
China BlueChemical's overall stock score of 70 is driven primarily by strong technical momentum, with the stock trading above key moving averages, and a reasonable valuation supported by a solid 4.89% dividend yield. Financial performance is mixed, with a stable balance sheet and positive cash flow growth offset by declining revenue and profit margins. The score reflects a cautiously optimistic outlook, with profitability challenges as the key risk to monitor.
China BlueChemical (3983) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$13.14B
Dividend Yield5.44%
Average Volume (3M)5.27M
Price to Earnings (P/E)10.6
Beta (1Y)0.51
Revenue Growth-8.24%
EPS Growth-24.53%
CountryHK
Employees3,653
SectorBasic Materials
Sector Strength58
IndustryAgricultural Inputs
Share Statistics
EPS (TTM)0.08
Shares Outstanding1,796,000,100
10 Day Avg. Volume5,961,174
30 Day Avg. Volume5,270,130
Financial Highlights & Ratios
PEG Ratio-0.16
Price to Book (P/B)0.51
Price to Sales (P/S)0.78
P/FCF Ratio10.14
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$3.10Price Target Upside24.00% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)0.31
Revenue Forecast (FY)HK$12.91B
China BlueChemical Business Overview & Revenue Model
Company Description
China BlueChemical Ltd., together with its subsidiaries, develops, manufactures, and sells mineral fertilizers and chemical products in the People's Republic of China and internationally. The company operates through Urea, Phosphorus and Compound ...
How the Company Makes Money
China BlueChemical generates revenue primarily through the sale of its chemical products, especially urea and other fertilizers, which are essential for agricultural productivity. The company's revenue model is based on both domestic and internati...
China BlueChemical Financial Statement Overview
Summary
Income Statement
45
Neutral
Balance Sheet
75
Positive
Cash Flow
60
Neutral
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 11.79B | 11.95B | 12.99B | 14.28B | 13.40B | 10.42B |
| Gross Profit | 1.55B | 1.70B | 2.06B | 2.54B | 2.94B | 1.33B |
| EBITDA | 1.33B | 1.55B | 3.33B | 2.35B | 2.76B | 1.32B |
| Net Income | 1.03B | 1.07B | 2.38B | 1.64B | 1.50B | 745.49M |
Balance Sheet | ||||||
| Total Assets | 24.57B | 24.08B | 24.32B | 23.50B | 21.43B | 20.75B |
| Cash, Cash Equivalents and Short-Term Investments | 13.69B | 13.51B | 13.74B | 12.55B | 11.23B | 10.17B |
| Total Debt | 2.34B | 2.12B | 2.02B | 2.08B | 1.05B | 1.98B |
| Total Liabilities | 5.00B | 4.57B | 4.91B | 5.72B | 4.52B | 5.12B |
| Stockholders Equity | 18.49B | 18.41B | 18.30B | 16.75B | 15.83B | 14.70B |
Cash Flow | ||||||
| Free Cash Flow | 238.05M | 918.02M | 800.48M | 806.70M | 1.88B | 890.36M |
| Operating Cash Flow | 638.95M | 1.52B | 1.54B | 2.14B | 2.94B | 1.26B |
| Investing Cash Flow | -505.34M | -379.00M | -691.13M | -2.35B | -3.66B | 1.11B |
| Financing Cash Flow | -172.77M | -1.06B | -784.06M | 56.35M | -1.37B | -415.86M |
China BlueChemical Technical Analysis
Neutral
2.50
Price Trends
2.87
Negative
2.68
Positive
2.47
Positive
Market Momentum
-0.03
Positive
47.27
Neutral
48.87
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:3983, the sentiment is Neutral. The current price of 2.5 is below the 20-day moving average (MA) of 3.00, below the 50-day MA of 2.87, and above the 200-day MA of 2.47, indicating a neutral trend. The MACD of -0.03 indicates Positive momentum. The RSI at 47.27 is Neutral, neither overbought nor oversold. The STOCH value of 48.87 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for HK:3983.
China BlueChemical Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | HK$11.59B | 7.77 | 11.27% | 3.66% | -0.34% | 64.10% | |
71 Outperform | HK$14.36B | 10.97 | 9.60% | 3.23% | 0.82% | 2.99% | |
70 Outperform | HK$13.14B | 10.56 | 5.56% | 5.44% | -8.24% | -24.53% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
54 Neutral | HK$13.90B | 87.42 | -0.50% | 1.16% | -15.17% | -125.24% | |
52 Neutral | HK$6.02B | 8.07 | 7.70% | ― | 9.20% | 213.87% |
* Basic Materials Sector Average
HK:3983
China BlueChemical
2.85
1.22
75.17%
HK:0297
Sinofert Holdings
1.65
0.57
52.78%
HK:1866
China XLX Fertiliser Ltd.
11.19
7.43
197.61%
HK:0509
Century Sunshine Group Holdings Limited
0.17
0.00
0.00%
HK:1907
China Risun Group Ltd.
3.12
0.67
27.14%
HK:2198
China Sanjiang Fine Chemicals Co., Ltd.
5.13
3.63
242.00%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.